Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

Recruiting now · Not applicable

Conditions studied: Hereditary Cancer Syndrome

In brief

The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention

Key facts

Study ID

NCT07195071

Run by

Columbia University

People needed

1000

Starts

2026-02-12

Expected to finish

2028-12-31

Last updated by the study team

2026-02-18

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age: 18 years - 55 years
• Patients receiving obstetrical-related care at a CUMC-affiliated enrollment site
• Patients who have elected to undergo OCS with the CUMC-affiliated obstetrics provider
• Patients with prior OCS but planned to repeat OCS are eligible
• Patients can speak and read in English or Spanish

You may not qualify if…

• Patients who have previously completed a multigene hereditary cancer syndrome panel
• Patients that have a hematologic cancer or hematologic pre-cancer
• Patients who have a history of an autologous bone marrow transplant

Where it is running

• Columbia University Irving Medical Center — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.